Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q47504348
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010715.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q47504348
|
024
|
|
|
‡a
0000-0002-7382-0339
‡2
orcid
|
024
|
|
|
‡a
9744915800
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q47504348
|
100
|
0 |
|
‡a
Teresa Cunha-Oliveira
‡9
ast
‡9
es
‡9
sl
|
375
|
|
|
‡a
2
‡2
iso5218
|
400
|
0 |
|
‡a
Teresa Cunha-Oliveira
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Teresa Cunha-Oliveira
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients
|
670
|
|
|
‡a
Author's Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.
|
670
|
|
|
‡a
Author's Acute effects of cocaine, morphine and their combination on bioenergetic function and susceptibility to oxidative stress of rat liver mitochondria
|
670
|
|
|
‡a
Author's Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity
|
670
|
|
|
‡a
Author's BDNF regulates BIM expression levels in 3-nitropropionic acid-treated cortical neurons.
|
670
|
|
|
‡a
Author's Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts.
|
670
|
|
|
‡a
Author's Bioenergetic dysfunction in Huntington's disease human cybrids.
|
670
|
|
|
‡a
Author's Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs
|
670
|
|
|
‡a
Author's Dimethylaminopyridine derivatives of lupane triterpenoids cause mitochondrial disruption and induce the permeability transition
|
670
|
|
|
‡a
Author's Disruption of striatal glutamatergic/GABAergic homeostasis following acute methamphetamine in mice
|
670
|
|
|
‡a
Author's Doxorubicin persistently rewires cardiac circadian homeostasis in mice
|
670
|
|
|
‡a
Author's Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
|
670
|
|
|
‡a
Author's Dysregulation of CREB activation and histone acetylation in 3-nitropropionic acid-treated cortical neurons: prevention by BDNF and NGF.
|
670
|
|
|
‡a
Author's Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.
|
670
|
|
|
‡a
Author's Hexavalent chromium, a lung carcinogen, confers resistance to thermal stress and interferes with heat shock protein expression in human bronchial epithelial cells
|
670
|
|
|
‡a
Author's Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease.
|
670
|
|
|
‡a
Author's Impact of Carcinogenic Chromium on the Cellular Response to Proteotoxic Stress
|
670
|
|
|
‡a
Author's Involvement of mitochondrial dysfunction in nefazodone-induced hepatotoxicity.
|
670
|
|
|
‡a
Author's Ketogenic diets: from cancer to mitochondrial diseases and beyond.
|
670
|
|
|
‡a
Author's Maternal obesity in sheep impairs fetal hepatic respiratory chain capacity
|
670
|
|
|
‡a
Author's Metabolic and Phenotypic Characterization of Human Skin Fibroblasts After Forcing Oxidative Capacity
|
670
|
|
|
‡a
Author's Mitochondrial apoptosis-inducing factor is involved in doxorubicin-induced toxicity on H9c2 cardiomyoblasts.
|
670
|
|
|
‡a
Author's Mitochondrial complex I dysfunction induced by cocaine and cocaine plus morphine in brain and liver mitochondria.
|
670
|
|
|
‡a
Author's Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine
|
670
|
|
|
‡a
Author's Molecular interaction between cocaine and opioids. Implications on Speedball's toxicity
|
670
|
|
|
‡a
Author's Neurotoxicity of heroin-cocaine combinations in rat cortical neurons
|
670
|
|
|
‡a
Author's Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention
|
670
|
|
|
‡a
Author's Reactivation of Dihydroorotate Dehydrogenase-Driven Pyrimidine Biosynthesis Restores Tumor Growth of Respiration-Deficient Cancer Cells
|
670
|
|
|
‡a
Author's Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
|
670
|
|
|
‡a
Author's Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease--resemblance to the effect of amphetamine drugs of abuse.
|
670
|
|
|
‡a
Author's Role of mtDNA-related mitoepigenetic phenomena in cancer.
|
670
|
|
|
‡a
Author's Single nanomolar doxorubicin exposure triggers compensatory mitochondrial responses in H9c2 cardiomyoblasts
|
670
|
|
|
‡a
Author's Street heroin induces mitochondrial dysfunction and apoptosis in rat cortical neurons
|
670
|
|
|
‡a
Author's Synthesis and cytotoxic profile of 3,4-methylenedioxymethamphetamine ("ecstasy") and its metabolites on undifferentiated PC12 cells: A putative structure-toxicity relationship
|
670
|
|
|
‡a
Author's β-adrenergic over-stimulation and cardio-myocyte apoptosis: two receptors, one organelle, two fates?
|
909
|
|
|
‡a
(orcid) 0000000273820339
‡9
1
|
909
|
|
|
‡a
(scopus) 9744915800
‡9
1
|
919
|
|
|
‡a
synthesisandcytotoxicprofileof34methylenedioxymethamphetamineecstasyanditsmetabolitesonundifferentiatedpc12cellsaputativestructuretoxicityrelationship
‡A
Synthesis and cytotoxic profile of 3,4-methylenedioxymethamphetamine ("ecstasy") and its metabolites on undifferentiated PC12 cells: A putative structure-toxicity relationship
‡9
1
|
919
|
|
|
‡a
βadrenergicoverstimulationandcardiomyocyteapoptosis2receptors1organelle2fates
‡A
β-adrenergic over-stimulation and cardio-myocyte apoptosis: two receptors, one organelle, two fates?
‡9
1
|
919
|
|
|
‡a
mitochondriatargetedcaffeicacidderivativerevertscellularandmitochondrialdefectsinhumanskinfibroblastsfrommalesporadicparkinsonsdiseasepatients
‡A
A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients
‡9
1
|
919
|
|
|
‡a
activationofigf1andinsulinsignalingpathwaysamelioratemitochondrialfunctionandenergymetabolisminhuntingtonsdiseasehumanlymphoblasts
‡A
Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.
‡9
1
|
919
|
|
|
‡a
acuteeffectsofcocainemorphineandtheircombinationonbioenergeticfunctionandsusceptibilitytooxidativestressofratlivermitochondria
‡A
Acute effects of cocaine, morphine and their combination on bioenergetic function and susceptibility to oxidative stress of rat liver mitochondria
‡9
1
|
919
|
|
|
‡a
alteredmitochondrialepigeneticsassociatedwithsubchronicdoxorubicincardiotoxicity
‡A
Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity
‡9
1
|
919
|
|
|
‡a
bdnfregulatesbimexpressionlevelsin3nitropropionicacidtreatedcorticalneurons
‡A
BDNF regulates BIM expression levels in 3-nitropropionic acid-treated cortical neurons.
‡9
1
|
919
|
|
|
‡a
berberineinducedcardioprotectionandsirt3modulationindoxorubicintreatedh9c2cardiomyoblasts
‡A
Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts.
‡9
1
|
919
|
|
|
‡a
bioenergeticdysfunctioninhuntingtonsdiseasehumancybrids
‡A
Bioenergetic dysfunction in Huntington's disease human cybrids.
‡9
1
|
919
|
|
|
‡a
cellularandmolecularmechanismsinvolvedintheneurotoxicityofopioidandpsychostimulantdrugs
‡A
Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs
‡9
1
|
919
|
|
|
‡a
dimethylaminopyridinederivativesoflupanetriterpenoidscausemitochondrialdisruptionandinducethepermeabilitytransition
‡A
Dimethylaminopyridine derivatives of lupane triterpenoids cause mitochondrial disruption and induce the permeability transition
‡9
1
|
919
|
|
|
‡a
disruptionofstriatalglutamatergicgabaergichomeostasisfollowingacutemethamphetamineinmice
‡A
Disruption of striatal glutamatergic/GABAergic homeostasis following acute methamphetamine in mice
‡9
1
|
919
|
|
|
‡a
doxorubicinpersistentlyrewirescardiaccircadianhomeostasisinmice
‡A
Doxorubicin persistently rewires cardiac circadian homeostasis in mice
‡9
1
|
919
|
|
|
‡a
doxorubicintriggersbioenergeticfailureandp53activationinmousestemcellderivedcardiomyocytes
‡A
Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
‡9
1
|
919
|
|
|
‡a
dysregulationofcrebactivationandhistoneacetylationin3nitropropionicacidtreatedcorticalneuronspreventionbybdnfandngf
‡A
Dysregulation of CREB activation and histone acetylation in 3-nitropropionic acid-treated cortical neurons: prevention by BDNF and NGF.
‡9
1
|
919
|
|
|
‡a
glutathioneredoxcycledysregulationinhuntingtonsdiseaseknockinstriatalcells
‡A
Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.
‡9
1
|
919
|
|
|
‡a
hexavalentchromiumalungcarcinogenconfersresistancetothermalstressandinterfereswithheatshockproteinexpressioninhumanbronchialepithelialcells
‡A
Hexavalent chromium, a lung carcinogen, confers resistance to thermal stress and interferes with heat shock protein expression in human bronchial epithelial cells
‡9
1
|
919
|
|
|
‡a
histonedeacetylaseinhibitorsprotectagainstpyruvatedehydrogenasedysfunctioninhuntingtonsdisease
‡A
Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease.
‡9
1
|
919
|
|
|
‡a
impactofcarcinogenicchromiumonthecellularresponsetoproteotoxicstress
‡A
Impact of Carcinogenic Chromium on the Cellular Response to Proteotoxic Stress
‡9
1
|
919
|
|
|
‡a
involvementofmitochondrialdysfunctioninnefazodoneinducedhepatotoxicity
‡A
Involvement of mitochondrial dysfunction in nefazodone-induced hepatotoxicity.
‡9
1
|
919
|
|
|
‡a
ketogenicdietsfromcancertomitochondrialdiseasesandbeyond
‡A
Ketogenic diets: from cancer to mitochondrial diseases and beyond.
‡9
1
|
919
|
|
|
‡a
maternalobesityinsheepimpairsfetalhepaticrespiratorychaincapacity
‡A
Maternal obesity in sheep impairs fetal hepatic respiratory chain capacity
‡9
1
|
919
|
|
|
‡a
metabolicandphenotypiccharacterizationofhumanskinfibroblastsafterforcingoxidativecapacity
‡A
Metabolic and Phenotypic Characterization of Human Skin Fibroblasts After Forcing Oxidative Capacity
‡9
1
|
919
|
|
|
‡a
mitochondrialapoptosisinducingfactorisinvolvedindoxorubicininducedtoxicityonh9c2cardiomyoblasts
‡A
Mitochondrial apoptosis-inducing factor is involved in doxorubicin-induced toxicity on H9c2 cardiomyoblasts.
‡9
1
|
919
|
|
|
‡a
mitochondrialcomplex1dysfunctioninducedbycocaineandcocaineplusmorphineinbrainandlivermitochondria
‡A
Mitochondrial complex I dysfunction induced by cocaine and cocaine plus morphine in brain and liver mitochondria.
‡9
1
|
919
|
|
|
‡a
mitochondrialdysfunctionandcaspaseactivationinratcorticalneuronstreatedwithcocaineoramphetamine
‡A
Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine
‡9
1
|
919
|
|
|
‡a
molecularinteractionbetweencocaineandopioidsimplicationsonspeedballstoxicity
‡A
Molecular interaction between cocaine and opioids. Implications on Speedball's toxicity
‡9
1
|
919
|
|
|
‡a
neurotoxicityofheroincocainecombinationsinratcorticalneurons
‡A
Neurotoxicity of heroin-cocaine combinations in rat cortical neurons
‡9
1
|
919
|
|
|
‡a
oxidativestressinamyotrophiclateralsclerosispathophysiologyandopportunitiesforpharmacologicalintervention
‡A
Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention
‡9
1
|
919
|
|
|
‡a
reactivationofdihydroorotatedehydrogenasedrivenpyrimidinebiosynthesisrestorestumorgrowthofrespirationdeficientcancercells
‡A
Reactivation of Dihydroorotate Dehydrogenase-Driven Pyrimidine Biosynthesis Restores Tumor Growth of Respiration-Deficient Cancer Cells
‡9
1
|
919
|
|
|
‡a
reprintofrevisitingoxidativestressandmitochondrialdysfunctioninthepathogenesisofparkinsondiseaseresemblancetotheeffectofamphetaminedrugsofabuse
‡A
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
‡9
1
|
919
|
|
|
‡a
revisitingoxidativestressandmitochondrialdysfunctioninthepathogenesisofparkinsondiseaseresemblancetotheeffectofamphetaminedrugsofabuse
‡A
Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease--resemblance to the effect of amphetamine drugs of abuse.
‡9
1
|
919
|
|
|
‡a
roleofmtdnarelatedmitoepigeneticphenomenaincancer
‡A
Role of mtDNA-related mitoepigenetic phenomena in cancer.
‡9
1
|
919
|
|
|
‡a
singlenanomolardoxorubicinexposuretriggerscompensatorymitochondrialresponsesinh9c2cardiomyoblasts
‡A
Single nanomolar doxorubicin exposure triggers compensatory mitochondrial responses in H9c2 cardiomyoblasts
‡9
1
|
919
|
|
|
‡a
streetheroininducesmitochondrialdysfunctionandapoptosisinratcorticalneurons
‡A
Street heroin induces mitochondrial dysfunction and apoptosis in rat cortical neurons
‡9
1
|
946
|
|
|
‡a
a
‡9
1
|
996
|
|
|
‡2
PTBNP|1149524
|
996
|
|
|
‡2
BLBNB|000260896
|
996
|
|
|
‡2
DNB|1253546290
|
996
|
|
|
‡2
DNB|1025159683
|
996
|
|
|
‡2
LC|n 2015188081
|
996
|
|
|
‡2
PTBNP|972948
|
996
|
|
|
‡2
NUKAT|n 2014168184
|
996
|
|
|
‡2
BLBNB|001515755
|
996
|
|
|
‡2
PTBNP|1888212
|
996
|
|
|
‡2
PTBNP|1903329
|
996
|
|
|
‡2
SUDOC|169397696
|
996
|
|
|
‡2
ISNI|0000000069326827
|
996
|
|
|
‡2
PTBNP|1301398
|
996
|
|
|
‡2
SUDOC|119762528
|
996
|
|
|
‡2
BLBNB|000331984
|
996
|
|
|
‡2
PTBNP|1049299
|
996
|
|
|
‡2
ISNI|0000000069925678
|
996
|
|
|
‡2
J9U|987007423860505171
|
996
|
|
|
‡2
ISNI|0000000067970483
|
996
|
|
|
‡2
PTBNP|447802
|
996
|
|
|
‡2
PLWABN|9810555244805606
|
996
|
|
|
‡2
SUDOC|245029583
|
996
|
|
|
‡2
PTBNP|959920
|
996
|
|
|
‡2
DNB|1057237973
|
996
|
|
|
‡2
DNB|1057137162
|
996
|
|
|
‡2
SUDOC|146843517
|
996
|
|
|
‡2
SUDOC|117959782
|
996
|
|
|
‡2
LC|n 2015003234
|
996
|
|
|
‡2
LC|no2009166648
|
996
|
|
|
‡2
BLBNB|000256948
|
996
|
|
|
‡2
PTBNP|1898333
|
996
|
|
|
‡2
BLBNB|000589181
|
996
|
|
|
‡2
DNB|1262602173
|
996
|
|
|
‡2
ISNI|0000000080184751
|
996
|
|
|
‡2
ISNI|0000000070014054
|
996
|
|
|
‡2
BIBSYS|90919447
|
996
|
|
|
‡2
LC|no2003123385
|
996
|
|
|
‡2
ISNI|0000000070540409
|
996
|
|
|
‡2
BLBNB|000311044
|
996
|
|
|
‡2
BLBNB|000311049
|
996
|
|
|
‡2
BLBNB|001115976
|
996
|
|
|
‡2
NUKAT|n 2013013157
|
996
|
|
|
‡2
ISNI|0000000428273764
|
996
|
|
|
‡2
ISNI|0000000070338067
|
996
|
|
|
‡2
PTBNP|102675
|
996
|
|
|
‡2
PTBNP|952342
|
996
|
|
|
‡2
PTBNP|1212834
|
996
|
|
|
‡2
PTBNP|1594587
|
996
|
|
|
‡2
PTBNP|264153
|
996
|
|
|
‡2
BLBNB|001020040
|
996
|
|
|
‡2
ISNI|0000000049044160
|
996
|
|
|
‡2
ISNI|0000000431730815
|
996
|
|
|
‡2
RERO|A000124651
|
996
|
|
|
‡2
ISNI|0000000445277329
|
996
|
|
|
‡2
BLBNB|000532650
|
996
|
|
|
‡2
DNB|1056380187
|
996
|
|
|
‡2
ISNI|0000000068299011
|
996
|
|
|
‡2
PTBNP|175123
|
996
|
|
|
‡2
SUDOC|084578688
|
996
|
|
|
‡2
SZ|1025159683
|
996
|
|
|
‡2
NTA|329803077
|
996
|
|
|
‡2
PTBNP|1299503
|
996
|
|
|
‡2
ISNI|0000000026794188
|
996
|
|
|
‡2
LIH|LNB:V-53519;=BJ
|
996
|
|
|
‡2
ISNI|0000000067792234
|
996
|
|
|
‡2
ISNI|0000000069083474
|
996
|
|
|
‡2
BLBNB|000280663
|
996
|
|
|
‡2
BNF|17903512
|
996
|
|
|
‡2
PTBNP|1160036
|
996
|
|
|
‡2
PTBNP|1477294
|
996
|
|
|
‡2
NSK|000308280
|
996
|
|
|
‡2
LC|n 2024038708
|
996
|
|
|
‡2
SUDOC|168542900
|
996
|
|
|
‡2
ISNI|0000000139410179
|
996
|
|
|
‡2
PTBNP|189412
|
996
|
|
|
‡2
DNB|1139517546
|
996
|
|
|
‡2
ISNI|0000000070428257
|
996
|
|
|
‡2
BNF|16920931
|
996
|
|
|
‡2
BNF|14488164
|
996
|
|
|
‡2
NTA|141488220
|
996
|
|
|
‡2
DNB|1089205961
|
996
|
|
|
‡2
ISNI|0000000071678047
|
996
|
|
|
‡2
DNB|1147230498
|
996
|
|
|
‡2
DNB|1069384496
|
996
|
|
|
‡2
LC|nr2001049266
|
996
|
|
|
‡2
DE633|pe50054843
|
996
|
|
|
‡2
LC|n 84023700
|
996
|
|
|
‡2
LC|no 95018374
|
996
|
|
|
‡2
PTBNP|965763
|
996
|
|
|
‡2
NII|DA19115788
|
996
|
|
|
‡2
PTBNP|1891954
|
996
|
|
|
‡2
PTBNP|1540918
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|